James E Flynn Insider Trading $PRX PAR PHARMACEUTICAL COMPANIES, INC.
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in SALIX PHARMACEUTICALS LTD ($SLXP) and 10% Owner in ANADYS PHARMACEUTICALS INC ($ANDS) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Invitae Corp ($NVTA).
James E Flynn in PAR PHARMACEUTICAL COMPANIES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 2,108,213 shares
Latest Transaction: Aug 19 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James E Flynn in PAR PHARMACEUTICAL COMPANIES, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANDS, AUXL, CAMY.OB, DRNA, EHTH, NVTA, PRX, TARA, SLXP, VNDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.50 | 6,100 | 106,750 | 2,108,213 | 2.1 M to 2.1 M (-0.29 %) |
| Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.48 | 31,845 | 556,651 | 2,114,313 | 2.1 M to 2.1 M (-1.48 %) |
| Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.66 | 103,900 | 1,834,874 | 2,146,158 | 2.3 M to 2.1 M (-4.62 %) |
| Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.93 | 18,009 | 322,901 | 2,250,058 | 2.3 M to 2.3 M (-0.79 %) |
| Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.81 | 35,000 | 623,350 | 2,268,067 | 2.3 M to 2.3 M (-1.52 %) |
| Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.85 | 1,700 | 30,345 | 2,303,067 | 2.3 M to 2.3 M (-0.07 %) |
| Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.47 | 43,862 | 766,269 | 2,304,767 | 2.3 M to 2.3 M (-1.87 %) |
| Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.42 | 2,219 | 23,122 | 2,348,629 | 2.4 M to 2.3 M (-0.09 %) |
| Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.42 | 1,281 | 13,348 | 1,355,787 | 1.4 M to 1.4 M (-0.09 %) |
| Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.40 | 18,513 | 192,535 | 2,350,848 | 2.4 M to 2.4 M (-0.78 %) |
| Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.40 | 10,687 | 111,145 | 1,357,068 | 1.4 M to 1.4 M (-0.78 %) |
| Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.45 | 89,267 | 932,840 | 2,369,361 | 2.5 M to 2.4 M (-3.63 %) |
| Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.45 | 51,533 | 538,520 | 1,367,755 | 1.4 M to 1.4 M (-3.63 %) |
Page: 1